Basilia Zingarelli Selected Research

ciglitazone

1/2010	Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock.
10/2008	Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.
11/2007	Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
12/2003	Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Basilia Zingarelli Research Topics

Disease

45	Sepsis (Septicemia) 01/2022 - 09/2003
28	Inflammation (Inflammations) 01/2019 - 01/2003
13	Lung Injury 09/2021 - 09/2003
12	Reperfusion Injury 07/2019 - 01/2003
10	Hemorrhage 01/2020 - 01/2008
10	Hemorrhagic Shock 01/2018 - 10/2008
9	Shock 01/2020 - 05/2002
8	Ischemia 10/2016 - 02/2002
8	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014 - 02/2002
7	Infections 10/2018 - 10/2011
7	Hypotension (Low Blood Pressure) 01/2018 - 05/2002
6	Septic Shock (Toxic Shock Syndrome) 07/2019 - 01/2003
5	Endotoxemia 06/2014 - 05/2007
4	Pneumonia (Pneumonitis) 05/2011 - 10/2008
4	Myocardial Reperfusion Injury 11/2007 - 02/2002
3	Acute Lung Injury 11/2019 - 02/2003
3	Critical Illness (Critically Ill) 11/2018 - 01/2010
3	Edema (Dropsy) 10/2018 - 01/2008
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2016 - 01/2003
3	Necrosis 07/2010 - 09/2007
3	Brain Injuries (Brain Injury) 05/2008 - 11/2002
3	Bacterial Meningitis 05/2008 - 11/2002
3	Meningitis 05/2008 - 11/2002
3	Colitis 01/2008 - 05/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2005 - 05/2003
2	Leukemia 01/2020 - 11/2018
2	Atherosclerosis 04/2011 - 12/2007
2	Multiple Organ Failure (MODS) 12/2003 - 09/2003
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Heart Arrest (Cardiac Arrest) 07/2019
1	Myocardial Infarction 07/2019
1	Pain (Aches) 01/2019
1	Pulmonary Edema 01/2019

Drug/Important Bio-Agent (IBA)

15	PPAR gammaIBA 01/2016 - 12/2003
14	NF-kappa B (NF-kB)IBA 10/2010 - 02/2002
13	LigandsIBA 01/2014 - 12/2003
10	CytokinesIBA 11/2019 - 02/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2007
7	Biological ProductsIBA 01/2022 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
7	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2016 - 12/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2002
6	LipopolysaccharidesIBA 01/2019 - 05/2007
6	Peroxidase (Myeloperoxidase)IBA 01/2019 - 03/2005
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2014 - 01/2010
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2005
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 09/2007
5	C-PeptideIBA 04/2014 - 05/2007
4	EnzymesIBA 01/2020 - 05/2003
4	ChemokinesIBA 01/2019 - 05/2007
4	Ringer's LactateIBA 01/2018 - 01/2017
4	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 10/2016 - 02/2012
4	Interleukin-10 (Interleukin 10)IBA 06/2014 - 09/2007
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2012 - 05/2005
4	ciglitazoneIBA 01/2010 - 12/2003
4	Poly (ADP-Ribose) Polymerase-1IBA 03/2005 - 05/2003
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 05/2011
3	AMP-Activated Protein KinasesIBA 11/2019 - 01/2018
3	AICA ribonucleotide (ZMP)IBA 10/2018 - 01/2017
3	CTCE-0214IBA 09/2016 - 06/2014
3	Liver X ReceptorsIBA 08/2015 - 08/2006
3	Therapeutic UsesIBA 08/2015 - 05/2007
3	Insulin (Novolin)FDA Link 07/2014 - 05/2007
3	TeaIBA 01/2008 - 01/2004
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2005 - 03/2002
3	parthenolideIBA 09/2003 - 02/2002
2	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2016
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 02/2011
2	erucylphosphocholineIBA 01/2019 - 06/2014
2	RNA (Ribonucleic Acid)IBA 11/2018 - 02/2012
2	Pioglitazone (Actos)FDA Link 11/2018 - 07/2014
2	Troponin IIBA 10/2018 - 01/2014
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 10/2017
2	LeptinIBA 01/2016 - 10/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2014 - 11/2013
2	Rosiglitazone (Avandia)FDA Link 07/2014 - 01/2008
2	AdipokinesIBA 11/2010 - 01/2010
2	AdiponectinIBA 11/2010 - 01/2010
2	beta-Arrestin 2IBA 07/2010 - 01/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2008 - 05/2007
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2008 - 09/2007
2	Surface-Active Agents (Surfactants)IBA 10/2007 - 02/2003
2	PolyphenolsIBA 09/2007 - 01/2004
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2005 - 05/2003
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2003 - 02/2003
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2002 - 02/2002
1	Syndecan-1 (Syndecan 1)IBA 09/2021
1	Cre recombinaseIBA 01/2020
1	AlbuminsIBA 01/2020
1	4- hydroxy- 3- (4- (2- hydroxyphenyl)phenyl)- 6- oxo- 7H- thieno(2,3- b)pyridine- 5- carbonitrileIBA 11/2019
1	Tight Junction ProteinsIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019

Therapy/Procedure

24	Punctures 01/2022 - 09/2003
24	Ligation 01/2022 - 09/2003
12	Resuscitation 07/2019 - 06/2009
9	Therapeutics 01/2019 - 11/2002
5	Critical Care (Surgical Intensive Care) 10/2018 - 10/2011
2	Intraperitoneal Injections 10/2016 - 04/2016
2	Rectal Administration 01/2008 - 05/2003
1	Euthanasia (Mercy Killing) 01/2019